Mimetogen Pharmaceuticals' Series B Round

Mimetogen Pharmaceuticals raised a round of funding on February 28, 2011. Investors include Medwell Capital.

Mimetogen is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinitis pigmentosa. The company desig…

Articles about Mimetogen Pharmaceuticals' Series B Round: